Study on intestinal absorption features of berberine hydrochloride phospholipid solid dispersions by rat single-pass perfusion model
10.7501/j.issn.0253-2670.2017.09.018
- Author:
Yong-Gui MA
1
Author Information
1. Department of Pharmacy, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
- Publication Type:Journal Article
- Keywords:
Absorption rate constant;
Apparent absorption coefficient;
Berberine hydrochloride;
Intestinal absorption;
Phospholipid solid dispersions;
Single-pass intestinal perfusion
- From:
Chinese Traditional and Herbal Drugs
2017;48(9):1820-1824
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To compare intestinal absorption features of berberine hydrochloride phospholipid solid dispersions (BBH-PSD) by rat single-pass perfusion model, and to explore the mechanism of berberine bioavailability increasing mechanism by phospholipid solid dispersion technology. Methods: The single-pass perfusion model was established in rats, the concentration of berberine in intestinal perfusion was determined by HPLC, and phospholipid solid dispersion technology promoting intestinal absorption of berberine was investigated. Results: Compared with berberine, BBH-PSD could promote much more absorption of berberine in various intestinal segments, especially in jejunum, and the mechanism was related to improving permeability and strengthen simple diffusion of berberine. The Ka and Papp values of BBH and BBH-PSD in jejunum were obviously higher than BBH (P < 0.05); When the volumetic flow rate of BBH-PSD was 0.2, 0.4, and 0.8 mL/min, Ka and Papp were both higher than BBH (P < 0.05); The increasing mass concentration was not obvious to intestinal absorption of BBH, while the increasing mass concentration of BBH-PSD obviously increased the intestinal absorption of BBH (P < 0.05). Conclusion: Intestinal absorption characteristics of berberine phospholipid solid dispersion is beneficial to improve berberine oral bioavailability, and it can provide a scientific basis for the development of new dosage forms of berberine hydrochloride.
